Parsabiv Injection, Solution
Product Images NDC 55513-741
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Parsabiv (NDC 55513-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel10 X 0.5 mL Single-dose Vialsndc 55513-740-10amgen®parsabivtm (etelcalcetide)injection2.5 mg/0.5 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 02)
Principal Display Panel10 X 1 mL Single-dose Vialsndc 55513-741-10amgen®parsabivtm (etelcalcetide)injection5 mg/mlfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 03)
Ndc 55513-742-10amgen®parsabivtm (etelcalcetide)injection10 mg/2 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.